Drug intelligence / Profile preview

salicylate

Development stage
Unknown
Modality
Small Molecules
Administration
Local Delivery
01

Overview

Salicylate is the unacetylated form of aspirin. It functions as a direct activator of AMP-activated protein kinase (Ampk) β1, a highly conserved serine/threonine kinase that plays a crucial role in regulating lipid and energy metabolism. Through this activation, salicylate improves macrophage cholesterol homeostasis by decreasing the synthesis of fatty acids and sterols, reducing cholesterol content (foam cell formation), and enhancing cholesterol efflux to HDL and apoA-I. It also increases the gene expression of ATP binding cassette transporters, Abcg1 and Abca1. Salicylate has demonstrated therapeutic potential for reducing foam cell formation in the early stages of atherosclerosis. Furthermore, it is a component of the Ideal BioStent, a bioabsorbable cardiology stent, where it is co-eluted with sirolimus for applications in interventional cardiology.

Other names
unacetylated form of aspirin
02

Targets

GAPDH (Glyceraldehyde-3-phosphate dehydrogenase)IKK complexHMGB1 (High mobility group protein B1)PRKAB1 (AMPK β1)

Beyond the preview

Go deeper on salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call